These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9223122)

  • 1. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging.
    Parnetti L; Tarducci R; Presciutti O; Lowenthal DT; Pippi M; Palumbo B; Gobbi G; Pelliccioli GP; Senin U
    Mech Ageing Dev; 1997 Jul; 97(1):9-14. PubMed ID: 9223122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
    Catani M; Cherubini A; Howard R; Tarducci R; Pelliccioli GP; Piccirilli M; Gobbi G; Senin U; Mecocci P
    Neuroreport; 2001 Aug; 12(11):2315-7. PubMed ID: 11496102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
    Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
    Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
    J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological neuronal decline in healthy aging human brain - An in vivo study with MRI and short echo-time whole-brain (1)H MR spectroscopic imaging.
    Ding XQ; Maudsley AA; Sabati M; Sheriff S; Schmitz B; Schütze M; Bronzlik P; Kahl KG; Lanfermann H
    Neuroimage; 2016 Aug; 137():45-51. PubMed ID: 27164326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
    Parnetti L; Lowenthal DT; Presciutti O; Pelliccioli GP; Palumbo R; Gobbi G; Chiarini P; Palumbo B; Tarducci R; Senin U
    J Am Geriatr Soc; 1996 Feb; 44(2):133-8. PubMed ID: 8576501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of the brain in dementia.
    De Stefano N; Mortilla M; Federico A
    Ital J Neurol Sci; 1999; 20(5 Suppl):S258-64. PubMed ID: 10662965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
    Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
    Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
    Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
    Lin AP; Shic F; Enriquez C; Ross BD
    MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.